Proper retention factor for Avanafil and Dapoxetine Hydrochloride Separation and Validation with RP-HPLC in Bulk, Dosage Form and Rat Plasma; Validation, Degradation, and Pharmacokinetic Application
Abstract
Environmental changes and fluctuated storage conditions are the main markers for API degradation and drug-drug interactions. Avanafil (Ava), phosphodiesterase inhibitor and dapoxetine (Dap), selective serotonin reuptake inhibitor helps to treat erectile dysfunction and increase ejaculation retention. The aim of the current study is to investigate the best chromatographic condition for the determination of Ava, Dap and their degradation products at different stress conditions and develop a sensitive, rapid, and reproducible method for their simultaneous estimation either in their combined dosage form or in rat plasma. The chromatographic conditions involve separation with RP-Eclipse-XDP C18 column, (25 cm ×4.6 mm, 5µ) column at 239 nm detection wavelength and mobile phase consisting of buffer (phosphate, pH 3) to acetonitrile with ratio 55:45 (v/v) and the injection volume was 20 µl. The method was subsequently used to evaluate the mixture of Ava and Dap pharmacokinetics in rat plasma. The pharmacokinetic parameters Cmax, Tmax, t1/2, AUC0- 24, AUCtotal, Ke, Vd, and CL of the cited drugs after oral administration was determined. The obtained data demonstrate that the method was applied successfully for separating each component and their degradation products with all accepted validation parameters and the method can be applied for preclinical pharmacokinetic investigation.
Read the paper
Related studies
- Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- A randomized, controlled trial of oral propranolol in infantile hemangioma
- Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study
- Increased physical activity improves sleep and mood outcomes in inactive people with insomnia: a randomized controlled trial
- COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.